120 related articles for article (PubMed ID: 15732132)
1. Simultaneous detection of HER2/neu gene amplification and protein overexpression in paraffin-embedded breast cancer.
Lottner C; Schwarz S; Diermeier S; Hartmann A; Knuechel R; Hofstaedter F; Brockhoff G
J Pathol; 2005 Apr; 205(5):577-84. PubMed ID: 15732132
[TBL] [Abstract][Full Text] [Related]
2. Validation of Dual-Color Dual In Situ Hybridization for HER2/neu Gene in Breast Cancer.
Rathi A; Sahay A; Shet TM; Patil A; Desai SB
Arch Pathol Lab Med; 2024 Apr; 148(4):453-460. PubMed ID: 37490416
[TBL] [Abstract][Full Text] [Related]
3. Metaplastic breast carcinomas exhibit EGFR, but not HER2, gene amplification and overexpression: immunohistochemical and chromogenic in situ hybridization analysis.
Reis-Filho JS; Milanezi F; Carvalho S; Simpson PT; Steele D; Savage K; Lambros MB; Pereira EM; Nesland JM; Lakhani SR; Schmitt FC
Breast Cancer Res; 2005; 7(6):R1028-35. PubMed ID: 16280056
[TBL] [Abstract][Full Text] [Related]
4. Performance of HER2 DAKO HercepTest and Ventana 4B5 immunohistochemical assays on detecting HER2 gene-amplification in uterine serous carcinomas.
Navarro Sanchez JM; Finkelman BS; Tyburski H; Turner BM; Moisini I; Katerji H; Varghese S; Wang X; Schiffhauer LM; Chen JJ; Hicks DG; Zhang H
Hum Pathol; 2024 May; 148():51-59. PubMed ID: 38740270
[TBL] [Abstract][Full Text] [Related]
5. HER2 overexpression and amplification is present in a subset of ovarian mucinous carcinomas and can be targeted with trastuzumab therapy.
McAlpine JN; Wiegand KC; Vang R; Ronnett BM; Adamiak A; Köbel M; Kalloger SE; Swenerton KD; Huntsman DG; Gilks CB; Miller DM
BMC Cancer; 2009 Dec; 9():433. PubMed ID: 20003286
[TBL] [Abstract][Full Text] [Related]
6. HER2/neu, Topoisomerase 2a, Estrogen and Progesterone Receptors: Discordance between Primary Breast Cancer and Metastatic Axillary Lymph Node in Expression and Amplification Characteristics.
Ataseven B; Gologan D; Gunesch A; Kehl V; Hoegel B; Beer M; Eiermann W
Breast Care (Basel); 2012 Dec; 7(6):465-70. PubMed ID: 24715828
[TBL] [Abstract][Full Text] [Related]
7. Comparison of Dako HercepTest and Ventana PATHWAY anti-HER2 (4B5) tests and their correlation with silver
Miladinović M; Vučković L; Klisic A
Open Med (Wars); 2021; 16(1):1503-1512. PubMed ID: 34708154
[TBL] [Abstract][Full Text] [Related]
8. Expression of HER2/neu is uncommon in human neuroblastic tumors and is unrelated to tumor progression.
Gambini C; Sementa AR; Boni L; Marino CE; Croce M; Negri F; Pistoia V; Ferrini S; Corrias MV
Cancer Immunol Immunother; 2003 Feb; 52(2):116-20. PubMed ID: 12594575
[TBL] [Abstract][Full Text] [Related]
9. Comparison of two quantitative polymerase chain reaction methods for detecting HER2/neu amplification.
Millson A; Suli A; Hartung L; Kunitake S; Bennett A; Nordberg MC; Hanna W; Wittwer CT; Seth A; Lyon E
J Mol Diagn; 2003 Aug; 5(3):184-90. PubMed ID: 12876209
[TBL] [Abstract][Full Text] [Related]
10. Signal transduction proteins in tumors from Puerto Rican and Caucasian gastric adenocarcinoma patients: expression differences with potential for specific targeted therapies.
Cangiano J; Centeno BA; Garrett CR; Cáceres W; de Jesús A; Lee JH; Pavía O; Jove R; Báez L; Sullivan DM; Muro-Cacho CA; Muñoz-Antonia T
Dig Dis Sci; 2008 Aug; 53(8):2090-100. PubMed ID: 18224443
[TBL] [Abstract][Full Text] [Related]
11. A splice variant of HER2 corresponding to Herstatin is expressed in the noncancerous breast and in breast carcinomas.
Koletsa T; Kostopoulos I; Charalambous E; Christoforidou B; Nenopoulou E; Kotoula V
Neoplasia; 2008 Jul; 10(7):687-96. PubMed ID: 18592003
[TBL] [Abstract][Full Text] [Related]
12. Beta class II tubulin predominates in normal and tumor breast tissues.
Dozier JH; Hiser L; Davis JA; Thomas NS; Tucci MA; Benghuzzi HA; Frankfurter A; Correia JJ; Lobert S
Breast Cancer Res; 2003; 5(5):R157-69. PubMed ID: 12927047
[TBL] [Abstract][Full Text] [Related]
13. Human Epidermal Growth Factor Receptor 2 (HER2/neu) in Salivary Gland Carcinomas: A Review of Literature.
Alotaibi AM; Alqarni MA; Alnobi A; Tarakji B
J Clin Diagn Res; 2015 Feb; 9(2):ZE04-8. PubMed ID: 25859537
[TBL] [Abstract][Full Text] [Related]
14. HER2/neu protein expression and fine needle breast aspiration from Argentinean patients with non-palpable breast lesions.
Domínguez WG; Nardi H; Montero H; Vincent E; Corte MM; Balogh GA
Exp Ther Med; 2010 Jul; 1(4):597-602. PubMed ID: 22993582
[TBL] [Abstract][Full Text] [Related]
15. HER2 staining of breast cancer is reduced under the current protocol of Ventana PATHWAY anti-HER-2/neu (4B5).
Horimoto Y; Onagi H; Watanabe J; Hayashi T
Pathol Int; 2024 Feb; 74(2):99-101. PubMed ID: 38197542
[No Abstract] [Full Text] [Related]
16. Single HER2-positive tumor cells are detected in initially HER2-negative breast carcinomas using the DEPArray™-HER2-FISH workflow.
Grüntkemeier L; Khurana A; Bischoff FZ; Hoffmann O; Kimmig R; Moore M; Cotter P; Kasimir-Bauer S
Breast Cancer; 2022 May; 29(3):487-497. PubMed ID: 35025065
[TBL] [Abstract][Full Text] [Related]
17. Correlation of Immunohistochemistry and Fluorescence
Bogdanovska-Todorovska M; Kostadinova-Kunovska S; Jovanovik R; Krsteska B; Kondov G; Kondov B; Petrushevska G
Open Access Maced J Med Sci; 2018 Apr; 6(4):593-599. PubMed ID: 29731922
[TBL] [Abstract][Full Text] [Related]
18. Standardization and optimization of fluorescence in situ hybridization (FISH) for HER-2 assessment in breast cancer: A single center experience.
Bogdanovska-Todorovska M; Petrushevska G; Janevska V; Spasevska L; Kostadinova-Kunovska S
Bosn J Basic Med Sci; 2018 May; 18(2):132-140. PubMed ID: 29389309
[TBL] [Abstract][Full Text] [Related]
19. Prognostic significance of HER3 in patients with malignant solid tumors.
Li Q; Zhang R; Yan H; Zhao P; Wu L; Wang H; Li T; Cao B
Oncotarget; 2017 Sep; 8(40):67140-67151. PubMed ID: 28978022
[TBL] [Abstract][Full Text] [Related]
20. Correlation of HER2 overexpression with gene amplification and its relation to chromosome 17 aneuploidy: a 5-year experience with invasive ductal and lobular carcinomas.
Nassar A; Khoor A; Radhakrishnan R; Radhakrishnan A; Cohen C
Int J Clin Exp Pathol; 2014; 7(9):6254-61. PubMed ID: 25337277
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
